Moreover, this study is the first to demonstrate cyclin D1-dependent pSmad2/3 and Smad4 expression in clinical HCC primary tumors, in which the association implicated a poor prognosis. This evidence concerns the gene SMAD4 and hepatocellular carcinoma.